<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">26480852</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>09</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>01</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1521-3773</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>54</Volume>
<Issue>49</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Angewandte Chemie (International ed. in English)</Title>
<ISOAbbreviation>Angew. Chem. Int. Ed. Engl.</ISOAbbreviation>
</Journal>
<ArticleTitle>Halogenated Phenazines that Potently Eradicate Biofilms, MRSA Persister Cells in Non-Biofilm Cultures, and Mycobacterium tuberculosis.</ArticleTitle>
<Pagination>
<MedlinePgn>14819-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/anie.201508155</ELocationID>
<Abstract>
<AbstractText>Conventional antibiotics are ineffective against non-replicating bacteria (for example, bacteria within biofilms). We report a series of halogenated phenazines (HP), inspired by marine antibiotic 1, that targets persistent bacteria. HP 14 demonstrated the most potent biofilm eradication activities to date against MRSA, MRSE, and VRE biofilms (MBEC = 0.2-12.5 μM), as well as the effective killing of MRSA persister cells in non-biofilm cultures. Frontline MRSA treatments, vancomycin and daptomycin, were unable to eradicate MRSA biofilms or non-biofilm persisters alongside 14. HP 13 displayed potent antibacterial activity against slow-growing M. tuberculosis (MIC = 3.13 μM), the leading cause of death by bacterial infection around the world. HP analogues effectively target persistent bacteria through a mechanism that is non-toxic to mammalian cells and could have a significant impact on treatments for chronic bacterial infections.</AbstractText>
<CopyrightInformation>© 2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garrison</LastName>
<ForeName>Aaron T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Dr., Gainesville, FL 32610 (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abouelhassan</LastName>
<ForeName>Yasmeen</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Dr., Gainesville, FL 32610 (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kallifidas</LastName>
<ForeName>Dimitris</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Dr., Gainesville, FL 32610 (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bai</LastName>
<ForeName>Fang</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Genetics &amp; Microbiology, University of Florida (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ukhanova</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of Florida, P.O. Box 100009, Gainesville, FL 32610 (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mai</LastName>
<ForeName>Volker</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, University of Florida, P.O. Box 100009, Gainesville, FL 32610 (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jin</LastName>
<ForeName>Shouguang</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Genetics &amp; Microbiology, University of Florida (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luesch</LastName>
<ForeName>Hendrik</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Dr., Gainesville, FL 32610 (USA).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huigens</LastName>
<ForeName>Robert W</ForeName>
<Initials>RW</Initials>
<Suffix>3rd</Suffix>
<AffiliationInfo>
<Affiliation>Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, 1345 Center Dr., Gainesville, FL 32610 (USA). rhuigens@cop.ufl.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Angew Chem Int Ed Engl</MedlineTA>
<NlmUniqueID>0370543</NlmUniqueID>
<ISSNLinking>1433-7851</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010619">Phenazines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000900">Anti-Bacterial Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000138">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018441">Biofilms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002470">Cell Survival</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002478">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006367">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055624">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000166">cytology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008826">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015394">Molecular Structure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009169">Mycobacterium tuberculosis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010619">Phenazines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000138">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013329">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">bacterial biofilms</Keyword>
<Keyword MajorTopicYN="N">biofilm eradication</Keyword>
<Keyword MajorTopicYN="N">halogenated phenazines</Keyword>
<Keyword MajorTopicYN="N">marine antibiotics</Keyword>
<Keyword MajorTopicYN="N">medicinal chemistry</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>08</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2015</Year>
<Month>09</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>9</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26480852</ArticleId>
<ArticleId IdType="doi">10.1002/anie.201508155</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>